Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Guangdong Provincial People's Hospital
Tempus AI
The First Affiliated Hospital of Soochow University
Tempus AI
Centre hospitalier de l'Université de Montréal (CHUM)
AstraZeneca
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
M.D. Anderson Cancer Center
Geneplus-Beijing Co. Ltd.
Peking University Third Hospital
Sun Yat-sen University
Insight Molecular Diagnostics
Bristol-Myers Squibb
Assiut University
Xiangya Hospital of Central South University
Oslo University Hospital
Hospices Civils de Lyon
Radiation Therapy Oncology Group
University Hospital, Grenoble
Samsung Medical Center